Tuesday 14 September - Conference Day Two
| | Morning Session Chair: Dr Dave Ager, DSM Research, USA |
| 08.55 | Opening Remarks
|
| 09.00 | Dr Ian Lennon, Chiral Quest Ltd, UK
Development of Highly Active Catalysts for Asymmetric Hydrogenation
|
| 09.45 | Dr Thomas Eisele, Hovione FarmaCiencia SA, Portugal
Process Development and Scale-Up of Tamsulosin – a Case Study
|
| 10.30 | Coffee and Exhibition
|
| 11.15 | Dr Pieter de Koning, Pfizer Global R&D UK
Fit for Purpose Enabling - Pragmatic Process Development to Support Early Phase Candidates |
| 12.00 | Steve Collier, Codexis, USA
The Development of Commercial Biocatalytic Processes to Simvastatin and Other Molecules Using Highly Evolved Enzymes |
| 12.45 | Lunch and Exhibition
|
14.00 - 17.30
| BIOCATALYSIS IN PHARMACEUTICAL MANUFACTURING:
A Special Session sponsored by Codexis
Speakers for this special session on Biocatalysis
- sponsored by Codexis - will be announced shortly. |
